![Medicine / Intellectual property law / Monopoly / Pharmaceutical sciences / Sulfoxides / Omeprazole / Supplementary protection certificate / Test data exclusivity / Astra AB / Proton pump inhibitors / AstraZeneca / Pharmacology Medicine / Intellectual property law / Monopoly / Pharmaceutical sciences / Sulfoxides / Omeprazole / Supplementary protection certificate / Test data exclusivity / Astra AB / Proton pump inhibitors / AstraZeneca / Pharmacology](https://www.pdfsearch.io/img/b99ded07333411fbd4bdab3b59fc6705.jpg) Date: 2010-10-13 11:06:53Medicine Intellectual property law Monopoly Pharmaceutical sciences Sulfoxides Omeprazole Supplementary protection certificate Test data exclusivity Astra AB Proton pump inhibitors AstraZeneca Pharmacology | | Antitrust AstraZeneca: the first abuse case in the pharmaceutical sector Niklas FAGERLUND and Søren Bo RASMUSSEN, Directorate-General Competition, unit B-2 1. IntroductionAdd to Reading ListSource URL: ec.europa.euDownload Document from Source Website File Size: 90,70 KBShare Document on Facebook
|